Lv55
1286 积分 2022-05-02 加入
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT
9小时前
待确认
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
1天前
待确认
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
2天前
已完结
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
4天前
已完结
Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes
8天前
已完结
Novel nonhormonal treatments for vasomotor symptoms of menopause
8天前
已关闭
Menopause review: Emerging treatments for menopausal symptoms
8天前
已完结
Advance of a new etomidate analogue — methoxyethyl etomidate hydrochloride (ET-26) for anesthesia induction in surgical patients
24天前
已完结
Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis
24天前
已完结
Pharmacokinetic-pharmacodynamic Modelling of NH600001 in Healthy Subjects and Patients Undergoing Gastroscopy
24天前
已完结
皖公网安备34019202002308
